Chimera Investment (NYSE:CIM – Get Free Report) had its target price lowered by Keefe, Bruyette & Woods from $13.00 to $11.50 in a research report issued to clients and investors on Monday, Benzinga reports. The firm presently has a “market perform” rating on the real estate investment trust’s stock. Keefe, Bruyette & Woods‘s price objective suggests a potential upside of 57.64% from the company’s previous close.
Separately, Weiss Ratings downgraded shares of Chimera Investment from a “sell (d+)” rating to a “sell (d)” rating in a research report on Friday, September 18th. One investment analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $13.67.
Get Our Latest Research Report on CIM
Chimera Investment Stock Performance
Shares of NYSE CIM traded down $0.01 during trading hours on Monday, reaching $7.29. The stock had a trading volume of 1,158,172 shares, compared to its average volume of 945,955. The firm has a market cap of $610.68 million, a price-to-earnings ratio of -2.38 and a beta of 1.75. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 2.34. Chimera Investment has a fifty-two week low of $7.18 and a fifty-two week high of $14.18. The firm has a 50-day moving average of $9.68 and a 200-day moving average of $12.17.
Chimera Investment (NYSE:CIM – Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The real estate investment trust reported $0.38 EPS for the quarter, missing the consensus estimate of $0.45 by ($0.07). The firm had revenue of ($118.00) million for the quarter, compared to analyst estimates of $103.10 million. Chimera Investment had a positive return on equity of 9.99% and a negative net margin of 19.11%.
Institutional Investors Weigh In On Chimera Investment
Several hedge funds have recently modified their holdings of the stock. StoneX Group Inc. acquired a new stake in shares of Chimera Investment in the 3rd quarter valued at approximately $220,000. International Assets Investment Management LLC boosted its stake in shares of Chimera Investment by 31.0% in the third quarter. International Assets Investment Management LLC now owns 26,695 shares of the real estate investment trust’s stock valued at $250,000 after buying an additional 6,311 shares in the last quarter. Kestra Advisory Services LLC boosted its stake in shares of Chimera Investment by 167.6% in the third quarter. Kestra Advisory Services LLC now owns 34,346 shares of the real estate investment trust’s stock valued at $327,000 after buying an additional 21,512 shares in the last quarter. Sigma Planning Corp boosted its stake in shares of Chimera Investment by 18.9% in the third quarter. Sigma Planning Corp now owns 18,423 shares of the real estate investment trust’s stock valued at $176,000 after buying an additional 2,929 shares in the last quarter. Finally, Simplicity Wealth LLC grew its holdings in Chimera Investment by 18.1% during the third quarter. Simplicity Wealth LLC now owns 83,244 shares of the real estate investment trust’s stock worth $793,000 after acquiring an additional 12,762 shares during the period. 48.44% of the stock is owned by institutional investors and hedge funds.
Chimera Investment Company Profile
Chimera Investment Corporation (NYSE:CIM) is a real estate investment trust that invests primarily in residential mortgage assets and other real estate-related investments. The company seeks to generate income from a portfolio that may include residential mortgage loans, agency and non-agency residential mortgage-backed securities, and other mortgage-related assets.
Chimera’s investments can include whole residential mortgage loans and securitized interests backed by mortgages. Its portfolio has historically included both agency assets, which carry guarantees from government-sponsored entities or government agencies, and non-agency assets, which generally involve greater credit exposure.
Recommended Stories
- Five stocks we like better than Chimera Investment
- Want to Escape the AI Sell-Off? This ETF Offers a Surprising Alternative
- America’s Rare Earth Clock Is Running Out, But the Bottleneck Isn’t Where You Think
- Atlassian Tanks After Huge Run as Guidance Disappoints, But Strength Remains
- Lemonade’s Revenue Soars 73%—So Why Did Its Stock Turn Sour After Earnings?
Receive News & Ratings for Chimera Investment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chimera Investment and related companies with MarketBeat.com's FREE daily email newsletter.
